We are live on ! Find out more
BDSX icon

Biodesix

42 hedge funds and large institutions have $23.1M invested in Biodesix in 2024 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 9

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

11% more funds holding

Funds holding: 38 → 42 (+4)

2.19% less ownership

Funds ownership: 18.87% → 16.67% (-2.2%)

38% less capital inflows, than outflows

Capital inflows: $2.97M | Capital outflows: $4.82M

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $4K

Holders
42
Holders Change
+4
Holders Change %
+10.53%
% of All Funds
0.6%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
8
Increased
14
Reduced
9
Closed
6
Calls
–
Puts
$4​K
Net Calls
-⁠$4​K
Net Calls Change
-⁠$4​K

BDSX Hedge Fund Activity: Q1 2024 in Review

42 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Biodesix (BDSX) for Q1 2024, worth a combined $23.1M — down 32% from $34.1M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new BDSX positions and 6 closed out — a net gain of 2 holders — while 14 added to existing stakes and 9 trimmed.

The largest buyer was Telemark Asset Management, adding an estimated $2.14M. The largest seller was AIGH Capital Management, cutting an estimated $2.29M.

  • 42 institutional investors held Biodesix (BDSX) as of Q1 2024, up from 38 in Q4 2023.
  • Funds reported $23.1M of Biodesix stock for Q1 2024, down 32% quarter-over-quarter.
  • 8 funds opened new Biodesix positions in Q1 2024 and 6 closed out, a net change of +2 holders.
  • The largest Biodesix buyer in Q1 2024 was Telemark Asset Management, an estimated $2.14M added.
  • The largest Biodesix seller in Q1 2024 was AIGH Capital Management, an estimated $2.29M sold.

Based on aggregated 13F filings for Q1 2024.